TRAJ13: A Protein Involved in T Cell Activation and Differentiation

Target Name: TRAJ13

NCBI ID: G28742

TRAJ13

Other Name(s): T cell receptor alpha joining 13

TRAJ13: A Protein Involved in T Cell Activation and Differentiation

T cell receptor alpha-joining 13 (TRAJ13) is a protein that is expressed in the T cells, a type of white blood cell that plays a crucial role in the immune system. T cells are responsible for recognizing and responding to foreign substances in the body, such as viruses and bacteria. When a T cell recognizes a foreign substance, it becomes activated and begins to divide and differentiate into a specialized type of cell called a T cell helper.

TRAJ13 is a protein that is expressed in T cells and is involved in the process of T cell activation and differentiation. It is made up of two chains of proteins that are held together by disulfide bonds. The chains contain several different regions, including an extracellular domain, a transmembrane domain, and an intracellular domain.

The extracellular domain of TRAJ13 is made up of a large extracellular region that is involved in cell adhesion and interaction. This region includes a region that is known as the N-terminal transmembrane domain, which is involved in the interaction between the protein and the cell membrane. The transmembrane domain is made up of a伪-helices and 尾-helices that are involved in the formation of the protein's transmembrane region.

The intracellular domain of TRAJ13 is made up of a large intracellular region that is involved in the interaction between the protein and various cellular signaling pathways. This region includes a region that is known as the coiled-coil region, which is involved in the formation of the protein's intracellular domain.

TRAJ13 is a protein that is involved in the process of T cell activation and differentiation. It is expressed in T cells and is involved in the interaction between the protein and various signaling pathways. As a result, it may be a drug target or biomarker for the development of new treatments for T cell-related diseases.

Protein Name: T Cell Receptor Alpha Joining 13

The "TRAJ13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRAJ13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets